© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Christine Blank
Articles
Review Links PFAS to Nonalcoholic Fatty Liver Disease
May 03, 2022
Article
Evaluation of 111 studies showed a link between the endocrine-disrupting chemicals and elevated levels of alanine aminotransferase, a liver enzyme elevated in people with nonalcoholic fatty liver disease.
Pharma Exec Details Hepatitis B Progress, New HBV
April 01, 2022
Article
VBI Vaccines’s PreHevbrio [Hepatitis B Vaccine (Recombinant)], the only approved 3-antigen hepatitis B vaccine for adults, is now commercially available in the U.S. after approval by the FDA late last year.
Alcohol’s Role in Liver Disease Deaths During COVID-19
April 01, 2022
Article
The overall number of deaths involving alcohol spiked 25.5% to 99,017 between 2019 and 2020.
MS Patients Warmed To Telehealth During the COVID-19 Pandemic
March 08, 2022
Article
Analysis of answers to online survey shows that telehealth use is high among people with multiple sclerosis (MS) amid the COVID-19 pandemic. Telehealth may be an appealing option for patients with MS who have physical impairments that make traveling to in-person appointments difficult.
New VCU Institute Aims to Transform Treatment of Liver Disease Care
March 02, 2022
Article
One of the priorities of the new institute at Virginia Commonwealth University’s medical school will be research into nonalcoholic steatohepatitis (NASH) as a key component in the emerging construct of metabolic health, says its leader, Arun J. Sanyal, M.D.